In the primary outcomes, elevated log2-ferritin levels were significantly associated with and increased risk of 365-day all-cause mortality in AP patients, while higher transferrin and TIBC levels were linked to reduced 365-day all-cause mortality risk. This evidence concerns the gene TF and alkaline phosphatase measurement.